Manuel Kadre - 13 Aug 2021 Form 4 Insider Report for Bright Health Group Inc. (NEUE)

Role: Director
Signature: /s/ Tonya LaBrec for Manuel Kadre, Attorney-in-Fact
Issuer symbol: NEUE
Transactions as of: 13 Aug 2021
Net transactions value: +$203,372
Form type: 4
Filing time: 17 Aug 2021, 17:03:08 UTC
Previous filing: 13 Aug 2021
Next filing: 10 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHG	Common Stock	Purchase	$17,787	+2,105	+3.7%	$8.45	58,766	13 Aug 2021	Direct	F1
transaction	BHG	Common Stock	Purchase	$185,585	+21,234	+36%	$8.74	80,000	16 Aug 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.435 to $8.45 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.56 to $8.99 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.435 to $8.45 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.56 to $8.99 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.